May 2 |
J.P. Morgan downgrades Metagenomi over Moderna deal termination
|
May 1 |
Metagenomi, Moderna terminate gene editing collaboration
|
May 1 |
Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems
|
Apr 8 |
Metagenomi to Present at Upcoming Scientific Meetings
|
Mar 27 |
Metagenomi reports FY results
|
Mar 27 |
Metagenomi Reports Business Updates and Full Year 2023 Financial Results
|
Mar 6 |
Jefferies, BMO bullish on newly public Metagenomi
|
Mar 2 |
Stocks To Watch: Eyes On Broadcom, Target, Costco, Rivian And Small Caps
|
Feb 29 |
Metagenomi to Participate in the 44th Annual Cowen Healthcare Conference
|
Feb 13 |
Metagenomi Announces Closing of Initial Public Offering
|